Back to Search Start Over

The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands.

Authors :
Hilton HG
McMurtrey CP
Han AS
Djaoud Z
Guethlein LA
Blokhuis JH
Pugh JL
Goyos A
Horowitz A
Buchli R
Jackson KW
Bardet W
Bushnell DA
Robinson PJ
Mendoza JL
Birnbaum ME
Nielsen M
Garcia KC
Hildebrand WH
Parham P
Source :
Cell reports [Cell Rep] 2017 May 16; Vol. 19 (7), pp. 1394-1405.
Publication Year :
2017

Abstract

HLA-B <superscript>∗</superscript> 46:01 was formed by an intergenic mini-conversion, between HLA-B <superscript>∗</superscript> 15:01 and HLA-C <superscript>∗</superscript> 01:02, in Southeast Asia during the last 50,000 years, and it has since become the most common HLA-B allele in the region. A functional effect of the mini-conversion was introduction of the C1 epitope into HLA-B <superscript>∗</superscript> 46:01, making it an exceptional HLA-B allotype that is recognized by the C1-specific natural killer (NK) cell receptor KIR2DL3. High-resolution mass spectrometry showed that HLA-B <superscript>∗</superscript> 46:01 has a low-diversity peptidome that is distinct from those of its parents. A minority (21%) of HLA-B <superscript>∗</superscript> 46:01 peptides, with common C-terminal characteristics, form ligands for KIR2DL3. The HLA-B <superscript>∗</superscript> 46:01 peptidome is predicted to be enriched for peptide antigens derived from Mycobacterium leprae. Overall, the results indicate that the distinctive peptidome and functions of HLA-B <superscript>∗</superscript> 46:01 provide carriers with resistance to leprosy, which drove its rapid rise in frequency in Southeast Asia.<br /> (Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
2211-1247
Volume :
19
Issue :
7
Database :
MEDLINE
Journal :
Cell reports
Publication Type :
Academic Journal
Accession number :
28514659
Full Text :
https://doi.org/10.1016/j.celrep.2017.04.059